Mallinckrodt Launches Generic Version of CONCERTA® in US

Published December 31, 2012

Mallinckrodt Launches Generic Version of CONCERTA® in US

Filed under: drug rehab treatment programs

LOUIS–(BUSINESS WIRE)– Mallinckrodt, the Pharmaceuticals business of Covidien (NYS: COV) , today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market a generic version of …
Read more on DailyFinance

FDA Approves New Drug by Bristol Myers and Pfizer (PFE, BMY)

Filed under: drug rehab treatment programs

The marketing challenge now facing Bristol Myers and Pfizer is to make Eliquis the drug of choice to treat people with atrial fibrillation. However, BMY and PFE both believe that this new drug will be a blockbuster. Bristol Myers share were up +2.51 …
Read more on Dividend.com (blog)

2. Addiction to strong narcotic pain-killers killing more

Filed under: drug rehab treatment programs

The bill puts the onus to design and administer the program on the shoulders of the state Board of Pharmacy and dictates that anyone who prescribes or dispenses certain prescription drugs must register with and use the program. “This is a tool, not a …
Read more on Nashua Telegraph